NuVasive
-
Financial
NuVasive to Participate in the 41st Annual J.P. Morgan Healthcare Conference
SAN DIEGO, Dec. 12, 2022 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with…
Read More » -
Spine
NuVasive Showcases Latest Innovation in Virtual Global Event
SAN DIEGO, Nov. 17, 2022 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with…
Read More » -
Spine
NuVasive to Sponsor and Participate at the Cervical Spine Research Society 50th Annual Meeting
SAN DIEGO, Nov. 14, 2022 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally…
Read More » -
Spine
NuVasive Launches Tube System and Excavation Micro for Posterior Spine Surgery
SAN DIEGO, Nov. 7, 2022 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with…
Read More » -
Spine
NuVasive Launches Reline Cervical for Posterior Cervical Fusion as Part of the C360 Portfolio
The cervical solution marks the completion of the NuVasive Reline fixation portfolio for complex deformity from occiput to sacrum SAN…
Read More » -
Spine
NuVasive to Sponsor and Participate at Society for Minimally Invasive Spine Surgery (SMISS) Annual Forum ’22
SAN DIEGO, Sept. 26, 2022 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with…
Read More » -
Spine
NuVasive Announces Departure of Chief Commercial Officer
SAN DIEGO, Aug. 9, 2022 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally…
Read More » -
Spine
NuVasive Opens Singapore Experience Center for Asia-Pacific region
New center supports the Company’s globalization efforts through increased surgeon training and education in Asia-Pacific region SAN DIEGO, June 29, 2022 /PRNewswire/ — NuVasive, Inc.…
Read More » -
Spine
NuVasive Simplify Cervical Disc Two-level Data Published in Journal of Neurosurgery: Spine
Peer-reviewed results from the two-level multi-center FDA Investigational Device Exemption study reiterate disc’s superiority to ACDF SAN DIEGO, April 21, 2022 /PRNewswire/…
Read More » -
Spine
Intertek Issues First UL 2900-2-1 Certification to Medical Device Manufacturer NuVasive, Inc.
The first UL 2900 certification issued by Intertek EWA-Canada signifies continued diversification of our core competencies and services March 7,…
Read More » -
Financial
NuVasive Announces Fourth Quarter and Full Year 2021 Financial Results and 2022 Outlook
–Pulse platform demonstrates strong performance in early adoption, including first international commercial contracts– –NuVasive Simplify Cervical Disc exceeds expectations in…
Read More » -
Spine
NuVasive Appoints Andrew C. Morton as Chief Human Resources Officer
SAN DIEGO, Jan. 31, 2022 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally…
Read More » -
Biologics
NuVasive Receives FDA Clearance for Expanded Indications of Use for Attrax Putty with Company’s Thoracolumbar Interbody Portfolio
Attrax Putty is the first and only synthetic biologic to receive 510(k) clearance for use with thoracolumbar interbody systems SAN…
Read More » -
Spine
NuVasive to Participate in 40th Annual J.P. Morgan Healthcare Conference
SAN DIEGO, Dec. 28, 2021 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with…
Read More » -
Biologics
Biocomposites signs distribution agreement with NuVasive Specialized Orthopedics to supply STIMULAN® in Germany
STIMULAN® is the first and only calcium matrix approved as an antibiotic carrier for use in bone and soft tissue…
Read More »